期刊论文详细信息
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 卷:132
The chitinase-like protein YKL-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthma
Article
Konradsen, Jon R.1,2,3  James, Anna3,4  Nordlund, Bjorn1,2,3  Reinius, Lovisa E.3,5  Soderhall, Cilla5  Melen, Erik4,6  Wheelock, Asa7  Carlsen, Karin C. Lodrup8,9  Lidegran, Marika1  Verhoek, Marri10  Boot, Rolf G.10  Dahlen, Barbro3,11  Dahlen, Sven Erik3,4  Hedlin, Gunilla1,2,3 
[1] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
[3] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden
[4] Karolinska Inst, Natl Inst Environm Med, Stockholm, Sweden
[5] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden
[6] Sachs Children & Youth Hosp, Stockholm, Sweden
[7] Karolinska Inst, Dept Med, Resp Med Unit, Stockholm, Sweden
[8] Oslo Univ Hosp, Dept Pediat, Oslo, Norway
[9] Univ Oslo, Oslo, Norway
[10] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands
[11] Karolinska Univ Hosp, Dept Med, Div Resp Med & Allergy Res, Huddinge, Sweden
关键词: Asthma;    children;    inflammation;    airway remodeling;    chitinases;    imaging;    genes;   
DOI  :  10.1016/j.jaci.2013.03.003
来源: Elsevier
PDF
【 摘 要 】

Background: Problematic severe childhood asthma includes a subgroup of patients who are resistant to therapy. The specific mechanisms involved are unknown, and novel biomarkers are required to facilitate treatment and diagnosis of therapy-resistant asthma. The chitinase-like protein YKL-40 has been related to asthma and airway remodeling. Objectives: To compare serum YKL-40 levels in children with severe, therapy-resistant asthma (n 5 34), children with controlled persistent asthma (n = 39), and healthy controls (n = 27), and to investigate correlations with biomarkers of inflammation and airway remodeling. Methods: The study protocol included questionnaires, measurement of exhaled nitric oxide in exhaled air, blood sampling for inflammatory biomarkers, and high-resolution computed tomography of the lungs to identify bronchial wall thickening (therapy-resistant only). Serum YKL-40 levels were measured by ELISA, and all asthmatic children were genotyped for a CHI3L1 promoter single nucleotide polymorphism (rs4950928). Results: Serum YKL-40 levels were significantly higher in children with therapy-resistant asthma than in healthy children (19.2 ng/mL vs 13.8 ng/mL, P = .03). Among children with severe, therapy-resistant asthma, YKL-40 levels correlated with fraction of exhaled nitric oxide in exhaled air (r = 0.48, P = .004), blood neutrophils (r = 0.63, P < .001), and bronchial wall thickening on high-resolution computed tomography (r = 0.45, P = .01). Following adjustment for CHI3L1 genotype, significantly greater levels of YKL-40 were found in children with therapy-resistant asthma than in children with controlled asthma. Conclusions: YKL-40 levels are increased in children with severe, therapy-resistant asthma compared to healthy children, and also compared to children with controlled asthma following correction for genotype.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jaci_2013_03_003.pdf 758KB PDF download
  文献评价指标  
  下载次数:24次 浏览次数:1次